Cholesterol Treatment Center, Concord Hospital, Suite #210, Concord, NH 03301, USA.
Curr Atheroscler Rep. 2009 Nov;11(6):470-6. doi: 10.1007/s11883-009-0070-2.
Hyperlipidemia is a risk factor for the development of coronary heart disease. Many patients decline prescription lipid-lowering agents and opt instead for supplements. Before any supplement can be routinely recommended it is crucial to examine the types of clinical trials that have been performed, the mechanism by which a supplement is felt to alter lipids, the population studied, potential adverse effects, and the possibility that investigators might be biased. Clinical trial evidence strongly supports the notion that both red yeast rice and plant stanols and sterols effectively lower low-density lipoprotein (LDL) cholesterol. Preliminary evidence supports the possibility that green tea catechins and black tea theaflavins may lower LDL. Data do not support an LDL-lowering claim for guggulipid, policosanol, or cinnamon. Finally, there is strong clinical trial evidence suggesting that marine omega-3 fatty acids lower triglycerides.
高脂血症是冠心病发展的一个危险因素。许多患者拒绝开处方的降脂药物,而选择补充剂。在常规推荐任何补充剂之前,检查已进行的临床试验类型、补充剂被认为改变脂质的机制、研究人群、潜在的不良反应以及研究人员可能存在偏见的可能性至关重要。临床试验证据强烈支持这样一种观点,即红曲米和植物甾醇和甾烷醇都能有效地降低低密度脂蛋白(LDL)胆固醇。初步证据支持绿茶儿茶素和红茶茶黄素可能降低 LDL 的可能性。没有数据支持对古胶脂、植物固醇或肉桂降低 LDL 的说法。最后,有强有力的临床试验证据表明,海洋ω-3 脂肪酸可降低甘油三酯。